Yüklüyor......
Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives
Low-density lipoprotein lowering with statins has convincingly and consistently proven to reduce cardiovascular events in both primary and secondary prevention. However, despite high-dose statin therapy, residual cardiovascular risk remains and many patients also do not tolerate statins. Ezetimibe w...
Kaydedildi:
| Yayımlandı: | Cardiol Res Pract |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338976/ https://ncbi.nlm.nih.gov/pubmed/32670636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9815016 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|